Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia-Reference-Cited by-同舟云学术

Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia

Published:2022-02-24 Issue:6 Volume:34 Page:375-380
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Komatsu Toshiaki¹^ORCID,Nakamura Miho¹,Uchiyama Katsufumi²,Inoue Gen²,Sakanoue Kazumi¹,Kawamura Atsushi¹,Hiratsuka Koki¹,Takayama Yoko³,Takaso Masashi²,Atsuda Koichiro⁴

Affiliation:

1. Department of Pharmacy, Kitasato University Hospital, Sagamihara, Japan

2. Department of Orthopaedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan

3. Department of Infection Control and Infectious Diseases, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan

4. Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Sagamihara, Japan

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2022.2043538

Reference23 articles.

1. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

2. Linezolid penetration into osteo-articular tissues

3. Thrombocytopenia Associated with Linezolid Therapy

4. Hematologic Effects of Linezolid: Summary of Clinical Experience

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

2. Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients;European Journal of Clinical Pharmacology;2024-05-27

3. Treatment Approaches to Mycobacterium abscessus Pulmonary Disease;Clinics in Chest Medicine;2023-12

4. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease;Clinics in Chest Medicine;2023-12

5. Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoring;Pharmacology & Therapeutics;2023-06